Does depression hurt?

Journal of Clinical Psychiatry

Volumn 63, Issue 4, 2002, Pages 273-274

  Stahl, Stephen M ^a  

^a NEUROSCIENCE EDUCATION INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; DULOXETINE; MILNACIPRAN; NORADRENALIN; NORADRENALIN UPTAKE INHIBITOR; SEROTONIN; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

DEPRESSION; NORADRENERGIC SYSTEM; PHYSICAL DISEASE; PRIORITY JOURNAL; REMISSION; SEROTONINERGIC SYSTEM; SHORT SURVEY; SYMPTOMATOLOGY;

EID: 0036238595     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v63n0401     Document Type: Short Survey

References (8)

1. Somatization and the recognition of depression and anxiety in primary care
2. Why settle for silver when you can go for gold? Response vs. recovery as the goal of antidepressant therapy
3. Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors
4. Duloxetine, 60 mg once daily, for major depressive disorder: A randomized double-blind placebo-controlled trial
5. The psychopharmacology of energy and fatigue